$1.04 Million Grant From U.S. Army to UT Arlington For Stem Cell Research For Soldiers Living with Posttraumatic Osteoarthritis

Share with:

FacebookTwitterGoogle


Lipin Tang, a UT Arlington bioengineering professor aims to regenerate cartilage tissue and reduce osteoarthritis using a patient’s own stem cells (the same types of cells that Celltex uses in our technology) through the injection of microscaffolding. Tang, who is using a $1.04 million grant from the United States Army is focusing his research primarily on soldiers who were severely injured in battle and who now suffer from Posttraumatic Osteoarthritis. Posttraumatic Osteoarthritis often occurs in soldiers who suffered broken bones from blast, sharnpel and gunshot wounds, and whose joints never properly healed from these injures.  Tang believes that this new treatment is not only aimed at reducing Posttraumatic Osteoarthritis, but also helping to find a cure by regenerating new cartilage tissue using a patient’s own stem cells.

Click here to read the full article.

The post $1.04 million grant from U.S. Army appeared first on Celltex Therapeutics.

Share with:

FacebookTwitterGoogle